Different epidemiology of bloodstream infections in COVID-19 compared to non-COVID-19 critically ill patients: a descriptive analysis of the Eurobact II study

202258 citationsJournal Articlegold Open Access

Authors

Niccolò Buetti · University of Geneva

Alexis Tabah · Queensland University of Technology

Ambre Loiodice

Stéphane Ruckly

Abdullah Tarık Aslan · Hacettepe University

Giorgia Montrucchio · Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

Andrea Cortegiani · Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo

Neşe Saltoğlu

Abstract

We showed that the epidemiology of HABSI differed between COVID-19 and non-COVID-19 patients. Enterococcal HABSI predominated in COVID-19 patients. COVID-19 patients with HABSI had elevated risk of mortality. Trial registration ClinicalTrials.org number NCT03937245 . Registered 3 May 2019.

Topics & Keywords

Antibiotic Use and Resistance Sepsis Diagnosis and Treatment Nosocomial Infections in ICU

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Critical Care

Volume 26, Issue 1, pp. 319-319

DOI: 10.1186/s13054-022-04166-y

Field-Weighted Citation Impact: 5.41